{"id":212,"date":"2020-01-03T18:07:34","date_gmt":"2020-01-03T09:07:34","guid":{"rendered":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/?p=212"},"modified":"2020-04-06T00:39:58","modified_gmt":"2020-04-05T15:39:58","slug":"%e5%86%b2%e4%b8%ad%e8%a8%98%e5%bf%b5%e6%88%90%e4%ba%ba%e7%97%85%e7%a0%94%e7%a9%b6%e6%89%80%e3%80%80%e5%b7%9d%e7%ab%af%e8%8b%b1%e5%ad%9d","status":"publish","type":"post","link":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/achievement\/%e3%81%9d%e3%81%ae%e4%bb%96\/%e5%86%b2%e4%b8%ad%e8%a8%98%e5%bf%b5%e6%88%90%e4%ba%ba%e7%97%85%e7%a0%94%e7%a9%b6%e6%89%80%e3%80%80%e5%b7%9d%e7%ab%af%e8%8b%b1%e5%ad%9d\/","title":{"rendered":"\u51b2\u4e2d\u8a18\u5ff5\u6210\u4eba\u75c5\u7814\u7a76\u6240\u30fb\u7814\u7a76\u54e1\u3000\u5ddd\u7aef\u82f1\u5b5d"},"content":{"rendered":"<h4><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">\u5ddd\u7aef\u82f1\u5b5d\uff08\u304b\u308f\u3070\u305f\u3000\u3072\u3067\u305f\u304b\uff09<\/span><\/h4>\n<p><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-133\" src=\"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-292x300.jpg\" alt=\"\" width=\"82\" height=\"85\" srcset=\"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-292x300.jpg 292w, http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-768x790.jpg 768w, http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-545x560.jpg 545w, http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-250x257.jpg 250w, http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21-340x350.jpg 340w, http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-content\/uploads\/sites\/2\/2018\/07\/kawabata21.jpg 1767w\" sizes=\"(max-width: 82px) 100vw, 82px\" \/><\/span><\/p>\n<p><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\">\uff08\u30ad\u30e3\u30ea\u30a2\uff09\u30001988\u5e74\u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u5352\u696d\u5f8c\u3001\u540c\u5927\u5b66\u7b2c\u4e8c\u5916\u79d1\u5b66\u6559\u5ba4\u306b\u3066\u5916\u79d1\u306e\u57fa\u672c\u3092\u5b66\u3073\uff08\u51fa\u6708\u5eb7\u592b\u6559\u6388\u3001\u5e55\u5185\u96c5\u654f\u6559\u6388\uff09\u3001\u5c02\u9580\u5206\u91ce\u3068\u3057\u3066\u4e73\u817a\u5185\u5206\u6ccc\u5916\u79d1\u30b0\u30eb\u30fc\u30d7\u306b\u6240\u5c5e\u3057\u307e\u3057\u305f\u3002\u540c\u5927\u5b66\u7b2c\u4e8c\u5916\u79d1\u52a9\u624b\u3000JR\u6771\u4eac\u7dcf\u5408\u75c5\u9662\u5916\u79d1\u533b\u9577\u306a\u3069\u3092\u7d4c\u30662006\u5e749\u6708\u304b\u3089\u864e\u306e\u9580\u75c5\u9662\u4e73\u817a\u5185\u5206\u6ccc\u5916\u79d1\u90e8\u9577\u3068\u3057\u3066\u8d74\u4efb\u3057\u73fe\u5728\u306b\u81f3\u3063\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u57fc\u7389\u533b\u79d1\u5927\u5b66\u56fd\u969b\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u3066\u5b66\u4f4d\u3092\u53d6\u5f97\uff08\u6307\u5c0e\u6559\u5b98\uff1a\u4f50\u4f2f\u4fca\u662d\u4e73\u817a\u816b\u760d\u79d1\u6559\u6388\u30fb\u73fe\u75c5\u9662\u9577\uff09\u3057\u3001\u73fe\u5728\u3082\u57fc\u7389\u533b\u79d1\u5927\u5b66\u975e\u5e38\u52e4\u8b1b\u5e2b\u3092\u517c\u4efb\u3057\u3066\u304a\u308a\u307e\u3059\u3002\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u3067\u306f\u4e73\u817a\u5c02\u9580\u533b\u30fb\u6307\u5c0e\u533b\u30fb\u8a55\u8b70\u54e1\u3001\u7814\u7a76\u502b\u7406\u5be9\u67fb\u5c0f\u59d4\u54e1\u4f1a\u59d4\u54e1\u9577\u3001\u502b\u7406\u59d4\u54e1\u4f1a\u59d4\u54e1\u3001\u8a8d\u5b9a\u59d4\u54e1\u4f1a\u59d4\u54e1\u30fb\u95a2\u6771\u5730\u533a\u59d4\u54e1\u9577\u306a\u3069\u306e\u5f79\u306b\u3042\u308a\u30012019\u5e74\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u59d4\u54e1\u9577\u3092\u52d9\u3081\u307e\u3057\u305f\u3002<\/span><\/p>\n<p><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\">\uff08\u7814\u7a76\u5206\u91ce\uff09\u3000\u7814\u7a76\u5206\u91ce\u3067\u306f\u5b66\u4f4d\u53d6\u5f97\u3067\u304a\u4e16\u8a71\u306b\u306a\u3063\u305f\u6771\u4eac\u90fd\u5065\u5eb7\u9577\u5bff\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u7814\u7a76\u6240\u30fb\u4e95\u4e0a\u8061\u7814\u7a76\u90e8\u9577\uff08\u57fc\u7389\u533b\u79d1\u5927\u5b66\u30b2\u30ce\u30e0\u533b\u5b66\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u90e8\u9580\u9577\u517c\u4efb\uff09\u306e\u5143\u3067\u3001\u30db\u30eb\u30e2\u30f3\u4f9d\u5b58\u6027\u304c\u3093\u306b\u304a\u3051\u308b\u30b2\u30ce\u30e0\u30fb\u30a8\u30d4\u30b2\u30ce\u30e0\u30fb\u975e\u30b2\u30ce\u30e0\u4f5c\u7528\u89e3\u6790\u306b\u95a2\u308f\u3089\u305b\u3066\u3044\u305f\u3060\u3044\u3066\u304a\u308a\u3001\u305d\u306e\u4e2d\u3067\u864e\u306e\u9580\u75c5\u9662\u306e\u81e8\u5e8a\u691c\u4f53\u306a\u3089\u3073\u306b\u51b2\u4e2d\u8a18\u5ff5\u6210\u4eba\u75c5\u7814\u7a76\u6240\u306e\u65bd\u8a2d\u3092\u6d3b\u7528\u3055\u305b\u3066\u3044\u305f\u3060\u3044\u3066\u304a\u308a\u307e\u3059\u3002<\/span><\/p>\n<p><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\">\uff08\u4eca\u5f8c\u306e\u62b1\u8ca0\u3068\u30a2\u30d4\u30fc\u30eb\uff09\u3000\u79c1\u81ea\u8eab\u306f\u81e8\u5e8a\u533b\u3068\u3057\u3066\u3053\u308c\u307e\u3067\u591a\u304f\u306e\u60a3\u8005\u3055\u3093\u306e\u6cbb\u7642\u306b\u95a2\u308f\u308a\u3001\u591a\u304f\u306e\u7d4c\u9a13\u3092\u3055\u305b\u3066\u3044\u305f\u3060\u304d\u307e\u3057\u305f\u3002\u4eca\u5f8c\u306f\u57fa\u790e\u7814\u7a76\u8005\u3068\u5354\u529b\u3057\u306a\u304c\u3089\u81e8\u5e8a\u691c\u4f53\u3092\u7528\u3044\u305f\u7814\u7a76\u3092\u901a\u3058\u3066\u4e16\u306e\u4e2d\u306e\u304a\u5f79\u306b\u7acb\u3066\u308c\u3070\u3068\u8003\u3048\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3053\u3046\u3057\u305f\u6d3b\u52d5\u304c\u864e\u306e\u9580\u75c5\u9662\u306b\u6240\u5c5e\u3059\u308b\u82e5\u3044\u533b\u5e2b\u305f\u3061\u306e\u4eca\u5f8c\u306e\u30ad\u30e3\u30ea\u30a2\u30c7\u30d9\u30ed\u30c3\u30d7\u30e1\u30f3\u30c8\u306e\u4e00\u52a9\u306b\u306a\u308b\u3053\u3068\u3082\u540c\u6642\u306b\u9858\u3063\u3066\u3044\u307e\u3059\u3002<\/span><\/p>\n<p style=\"text-align: right\"><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\"><a href=\"https:\/\/okiken.tokyo\/scientist\/index.php?id=50\"><strong>\u51b2\u4e2d\u8a18\u5ff5\u6210\u4eba\u75c5\u7814\u7a76\u6240<\/strong><\/a><\/span><\/p>\n<h4 style=\"text-align: left\"><span style=\"font-family: georgia,palatino,serif;font-size: 10pt\">\u8ad6\u6587\u696d\u7e3e\uff082017\u5e74\u4ee5\u964d\uff09<\/span><\/h4>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Cancer Res (in press)<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Yuichi Mitobe, Kaori Iino, Ken-ichi Takayama, Kazuhiro Ikeda, Takashi Suzuki, Kenjiro Aogi, Hidetaka Kawabata, Yutaka Suzuki, Kuniko Horie-Inoue and Satoshi Inoue<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Cancer Sci. 2019 Nov 16. doi: 10.1111\/cas.14240. [Epub ahead of print] <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">RNA-binding protein NONO promotes breast cancer proliferation via posttranscriptional regulation of SKP2 and E2F8<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Iino, Kaori; Mitobe, Yuichi; Ikeda, Kazuhiro; Takayama, Kenichi; Suzuki, Takashi; Kawabata, Hidetaka; Suzuki, Yutaka; Horie-Inoue, Kuniko; Inoue, Satoshi<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Mol Cell Biol. 2019 Nov 12;39(23). pii: e00261-19. doi: 10.1128\/MCB.00261-19. Print 2019 Dec <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression. <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Yuichi Mitobea , Kazuhiro Ikeda , Takashi Suzuki , Kiyoshi Takagi , Hidetaka Kawabata , Kuniko Horie-Inoue and Satoshi Inoue<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">BMC Cancer. 2019 Oct 22;19(1):980. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Momoko Takahashi, Yukinori Ozaki, Rika Kizawa, Jun Masuda, Kentaro Sakamaki, Keiichi Kinowaki, Taro Umezu, Chihiro Kondoh, Yuko Tanabe, Nobuko Tamura, Yuji Miura, Takashi Shigekawa, Hidetaka Kawabata, Noriyuki Baba, Haruo Iguchi &amp; Toshimi Takano<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Breast. 2018 Apr 23;40:67-75 A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B\/ELTOP.<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Takano T, Tsurutani J, Takahashi M, Yamanaka T, Sakai K, Ito Y, Fukuoka J, Kimura H, Kawabata H, Tamura K, Matsumoto K, Aogi K, Sato K, Nishio K, Nakagawa K, Saeki T.<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Asia Pac J Clin Oncol. 2018 Mar 1. doi: 10.1111\/ajco.12863 A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens.<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Kikuchi Y, Uchida Y, Shirakawa K, Kanauchi H, Niwa T, Nishioka K, Tada K, Hashimoto M, Yasuda H, Sugiura R, Kawabata H, Seto Y, Ogawa T.<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Breast Cancer. 2018 May;25(3):343-349 Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Ozaki Y, Tanabe Y, Tamura N, Ogura T, Kondoh C, Miura Y, Yoshimura K, Kawabata H, Takano T.<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Int J Mol Sci. 2017 Sep 8;18(9). pii: E1931. <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">TRIM44 is a poor prognostic factor for breast cancer patients as a modulator of NF-\u03baB signaling<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Hidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, Ikuko Sugitani, Keiichi Kinowaki, Takeshi Fujii, Akihiko Osaki, Toshiaki Saeki, Kuniko Horie-Inoue, Satoshi Inoue<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Cancer Chemother Pharmacol. 2017 Jun;79(6):1179-1186 <\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Tanabe Y, Shimizu C, Hamada A, Hashimoto K, Ikeda K, Nishizawa D, Hasegawa J, Shimomura A, Ozaki Y, Tamura N, Yamamoto H, Yunokawa M, Yonemori K, Takano T, Kawabata H, Tamura K, Fujiwara Y.<\/span><br \/>\n<span style=\"font-family: arial,helvetica,sans-serif;font-size: 10pt\">Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5ddd\u7aef\u82f1\u5b5d\uff08\u304b\u308f\u3070\u305f\u3000\u3072\u3067\u305f\u304b\uff09 \uff08\u30ad\u30e3\u30ea\u30a2\uff09\u30001988\u5e74\u6771\u4eac\u5927\u5b66\u533b\u5b66\u90e8\u5352\u696d\u5f8c\u3001\u540c\u5927\u5b66\u7b2c\u4e8c\u5916\u79d1\u5b66\u6559\u5ba4\u306b\u3066\u5916\u79d1\u306e\u57fa\u672c\u3092\u5b66\u3073\uff08\u51fa\u6708\u5eb7\u592b\u6559\u6388\u3001\u5e55\u5185\u96c5\u654f\u6559\u6388\uff09\u3001\u5c02\u9580\u5206\u91ce\u3068\u3057\u3066\u4e73\u817a\u5185\u5206\u6ccc\u5916\u79d1\u30b0\u30eb\u30fc\u30d7\u306b\u6240\u5c5e\u3057\u307e\u3057\u305f\u3002\u540c\u5927\u5b66\u7b2c\u4e8c\u5916\u79d1\u52a9\u624b\u3000JR\u6771\u4eac\u7dcf\u5408\u75c5\u9662\u5916\u79d1\u533b\u9577\u306a\u3069\u3092\u7d4c\u30662006\u5e749\u6708\u304b\u3089\u864e\u306e\u9580\u75c5\u9662\u4e73\u817a\u5185\u5206\u6ccc\u5916\u79d1\u90e8\u9577\u3068\u3057\u3066\u8d74\u4efb\u3057\u73fe\u5728\u306b\u81f3\u3063\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u57fc\u7389\u533b\u79d1\u5927\u5b66\u56fd\u969b\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u3066\u5b66\u4f4d\u3092\u53d6\u5f97\uff08\u6307\u5c0e\u6559\u5b98\uff1a\u4f50\u4f2f\u4fca\u662d\u4e73\u817a\u816b\u760d\u79d1\u6559\u6388\u30fb\u73fe\u75c5\u9662\u9577\uff09\u3057\u3001\u73fe\u5728\u3082\u57fc\u7389\u533b\u79d1\u5927\u5b66\u975e\u5e38\u52e4\u8b1b\u5e2b\u3092\u517c\u4efb\u3057\u3066\u304a\u308a\u307e\u3059\u3002\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u3067\u306f\u4e73\u817a\u5c02\u9580\u533b\u30fb\u6307\u5c0e\u533b\u30fb\u8a55\u8b70\u54e1\u3001\u7814\u7a76\u502b\u7406\u5be9\u67fb\u5c0f\u59d4\u54e1\u4f1a\u59d4\u54e1\u9577\u3001\u502b\u7406\u59d4\u54e1\u4f1a\u59d4\u54e1\u3001\u8a8d\u5b9a\u59d4\u54e1\u4f1a\u59d4\u54e1\u30fb\u95a2\u6771\u5730\u533a\u59d4\u54e1\u9577\u306a\u3069\u306e\u5f79\u306b\u3042\u308a\u30012019\u5e74\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u7dcf\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u59d4\u54e1\u9577\u3092\u52d9\u3081\u307e\u3057\u305f\u3002 \uff08\u7814\u7a76\u5206\u91ce\uff09\u3000\u7814\u7a76\u5206\u91ce\u3067\u306f\u5b66\u4f4d\u53d6\u5f97\u3067\u304a\u4e16\u8a71\u306b\u306a\u3063\u305f\u6771\u4eac\u90fd\u5065\u5eb7\u9577\u5bff\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u7814\u7a76\u6240\u30fb\u4e95\u4e0a\u8061\u7814\u7a76\u90e8\u9577\uff08\u57fc\u7389\u533b\u79d1\u5927\u5b66\u30b2\u30ce\u30e0\u533b\u5b66\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u90e8\u9580\u9577\u517c\u4efb\uff09\u306e\u5143\u3067\u3001\u30db\u30eb\u30e2\u30f3\u4f9d\u5b58\u6027\u304c\u3093\u306b\u304a\u3051\u308b\u30b2\u30ce\u30e0\u30fb\u30a8\u30d4\u30b2\u30ce\u30e0\u30fb\u975e\u30b2\u30ce\u30e0\u4f5c\u7528\u89e3\u6790\u306b\u95a2\u308f\u3089\u305b\u3066\u3044\u305f\u3060\u3044\u3066\u304a\u308a\u3001\u305d\u306e\u4e2d\u3067\u864e\u306e\u9580\u75c5\u9662\u306e\u81e8\u5e8a\u691c\u4f53\u306a\u3089\u3073\u306b\u51b2\u4e2d\u8a18\u5ff5\u6210\u4eba\u75c5\u7814\u7a76\u6240\u306e\u65bd\u8a2d\u3092\u6d3b\u7528\u3055\u305b\u3066\u3044\u305f\u3060\u3044\u3066\u304a\u308a\u307e\u3059\u3002 \uff08\u4eca\u5f8c\u306e\u62b1\u8ca0\u3068\u30a2\u30d4\u30fc\u30eb\uff09\u3000\u79c1\u81ea\u8eab\u306f\u81e8\u5e8a\u533b\u3068\u3057\u3066\u3053\u308c\u307e\u3067\u591a\u304f\u306e\u60a3\u8005\u3055\u3093\u306e\u6cbb\u7642\u306b\u95a2\u308f\u308a\u3001\u591a\u304f\u306e\u7d4c\u9a13\u3092\u3055\u305b\u3066\u3044\u305f\u3060\u304d\u307e\u3057\u305f\u3002\u4eca\u5f8c\u306f\u57fa\u790e\u7814\u7a76\u8005\u3068\u5354\u529b\u3057\u306a\u304c\u3089\u81e8\u5e8a\u691c\u4f53\u3092\u7528\u3044\u305f\u7814\u7a76\u3092\u901a\u3058\u3066\u4e16\u306e\u4e2d\u306e\u304a\u5f79\u306b\u7acb\u3066\u308c\u3070\u3068\u8003\u3048\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3053\u3046\u3057\u305f\u6d3b\u52d5\u304c\u864e\u306e\u9580\u75c5\u9662\u306b\u6240\u5c5e\u3059\u308b\u82e5\u3044\u533b\u5e2b\u305f\u3061\u306e\u4eca\u5f8c\u306e\u30ad\u30e3\u30ea\u30a2\u30c7\u30d9\u30ed\u30c3\u30d7\u30e1\u30f3\u30c8\u306e\u4e00\u52a9\u306b\u306a\u308b\u3053\u3068\u3082\u540c\u6642\u306b\u9858\u3063\u3066\u3044\u307e\u3059\u3002 \u51b2\u4e2d\u8a18\u5ff5\u6210\u4eba\u75c5\u7814\u7a76\u6240 \u8ad6\u6587\u696d\u7e3e\uff082017\u5e74\u4ee5\u964d\uff09 Cancer Res (in press) PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2 Yuichi Mitobe, Kaori Iino, Ken-ichi Takayama, Kazuhiro Ikeda, Takashi Suzuki, Kenjiro Aogi, Hidetaka Kawabata, Yutaka Suzuki, Kuniko Horie-Inoue and Satoshi Inoue Cancer Sci. \u30fb\u30fb\u30fb<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-212","post","type-post","status-publish","format-standard","hentry","category-6"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/posts\/212"}],"collection":[{"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/comments?post=212"}],"version-history":[{"count":17,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/posts\/212\/revisions"}],"predecessor-version":[{"id":323,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/posts\/212\/revisions\/323"}],"wp:attachment":[{"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/media?parent=212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/categories?post=212"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.tokyo-breast-clinic.jp\/doctor\/wp-json\/wp\/v2\/tags?post=212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}